Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
367,80 B | 2,49% | 4/6 | 25,40% | -19,05% | 19,75% | DOWN |
|
Merck NYSE:MRK |
299,89 B | 7,67% | 6/6 | -21,36% | -5,00% | 9,54% | UP |
|
Abbott Laboratories NYSE:ABT |
174,69 B | 6,23% | 5/6 | 10,18% | 22,39% | 30,61% | DOWN |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
110,97 B | 13,44% | 6/6 | 6,43% | -0,97% | 27,90% | DOWN |
|
Bayer XTRA:BAYN |
39,42 B | -1,16% | 3/6 | -8,53% | -18,57% | 24,63% | UP |
|
Astellas Pharma TSE:4503 |
4.670,21 B | -8,40% | 3/5 | 107,23% | 38,50% | -4,10% | UP |
|
Phathom Pharmaceuticals NasdaqGS:PHAT |
1,00 B | 0,00% | 1/4 | 89,45% | -68,94% | 101,90% | UP |
|
Zevra Therapeutics NasdaqGS:ZVRA |
0,56 B | 9,76% | 3/5 | 34,55% | 25,16% | 142,87% | UP |
|
Heron Therapeutics NasdaqCM:HRTX |
0,16 B | 0,95% | 4/6 | 13,20% | 54,28% | 370,59% | DOWN |
|
RedHill Biopharma NasdaqCM:RDHL |
0,00 B | 221,42% | 2/6 | 0,00% | 0,00% | -100,00% | DOWN |
|
Trevena OTCPK:TRVN |
0,00 B | -28,66% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
Baudax Bio OTCPK:BXRX.Q |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | 0,00% | DOWN |
|
Nabriva Therapeutics OTCPK:NBRV.F |
0,00 B | -29,61% | 1/3 | 0,00% | 0,00% | 0,00% | DOWN |
